✦ LIBER ✦

Crossover Dose Escalation Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of R1663, an Oral Factor Xa Inhibitor, in Healthy Male Volunteers

✍ Scribed by Schmitt, Christophe; Pannier, Anne; McIntyre, Christine; Zandt, Hagen; Ciorciaro, Cornelia; Winters, Katie; Pepper, Tom

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, Tolerability, Pharmacokinetics,

✍ Hüttner, S.; Graefe-Mody, E. U.; Withopf, B.; Ring, A.; Dugi, K. A. 📂 Article 📅 2008 🏛 Sage Publications 🌐 English ⚖ 217 KB

Safety, pharmacodynamics, and pharmacoki

✍ Dagmar Kubitza; Michael Becka; Georg Wensing; Barbara Voith; Michael Zuehlsdorf 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 768 KB

Safety, pharmacokinetics, and pharmacody

✍ Gupta, Abhya; Yong, Chan-Loi; Madwed, Jeffrey B; Staehle, Hildegard; Wood, Chest 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Pharmacodynamics and Pharmacokinetics of

✍ Loprete, Luca; Leuratti, Chiara; Scarsi, Claudia; Radicioni, Milko 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 282 KB

A Phase 1, dose escalation study to eval

✍ Liang, Earvin; Liu, Wenzhong Jerry; Lohr, Lisa; Nguyen, Van; Lin, Holly; Munson, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND,

✍ U. Lopatin; G. Wolfgang; R. Kimberlin; D. Turnas; M. Cornprost; G. Chittick; C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB